Clinical Trials Sponsored by U.S. Army Medical Research Acquisition Activity

Total 326 results

U.S. Army Medical Research Acquisition Activity

Unknown

Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate Cancer

Prostate Cancer

United States
Tripler Army Medical Center
U.S. Army Medical Research Acquisition Activity

Unknown

Asthma In-Home Monitoring (AIM) Trial

Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines

United States
University of Arizona
U.S. Army Medical Research Acquisition Activity

Recruiting

Effect of Morning Light Exposure on Mood (BLM)

Suicidal Ideation | Regulation, Emotion

United States
University of Florida
U.S. Army Medical Research Acquisition Activity

Recruiting

BioFLO for Respiratory Recovery in SCI

Spinal Cord Injuries

United States
University of Arizona
U.S. Army Medical Research Acquisition Activity

Completed

A Non-Pharmacological Method for Enhancing Sleep in PTSD

PTSD | Sleep Problems

United States
University of Arizona
U.S. Army Medical Research Acquisition Activity

Completed

Bright Light Therapy for Treatment of Sleep Problems Following Mild Traumatic Brain Injury

Concussion, Mild | Sleep Problems | Post-Concussion Symptoms

United States
University of Arizona
U.S. Army Medical Research Acquisition Activity

Completed

Effects of Bright Light Therapy in Mild Traumatic Brain Injury

Concussion, Mild | Sleep Problems | Post-Concussion Symptoms

United States
U.S. Army Medical Research Acquisition Activity
The Geneva Foundation

Unknown

Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization System (PTV)

Prostate Cancer

United States
U.S. Army Medical Research Acquisition Activity
The Geneva Foundation

Unknown

External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the Prostate

Prostate Cancer

United States
Brigham and Women's Hospital
U.S. Army Medical Research Acquisition Activity

Recruiting

Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue

Multiple Sclerosis

United States
University of South Florida
U.S. Army Medical Research Acquisition Activity

Unknown

Prosthetic Smart Socket Technology to Improve Patient Interaction, Usability, Comfort, Fit, and Function.

Complications of the Amputated Limb

United States
NeuroWave Systems Inc.
Fraser Health; U.S. Army Medical Research Acquisition Activity

Completed

Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia

Depth of Anesthesia (DOA)

Canada
Jonsson Comprehensive Cancer Center
U.S. Army Medical Research and Development Command; U.S. Army Medical Research...

Completed

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

Breast Carcinoma | Malignant Breast Neoplasm | Benign Breast Neoplasm

United States
American Burn Association
University of California, Davis; U.S. Army Medical Research Acquisition Activity

Completed

The Acute Burn Resuscitation Multicenter Prospective Observational Trial (ABRUPT)

Burns | Shock

United States
Johns Hopkins University
U.S. Army Medical Research Acquisition Activity; Armed Forces Institute of...

Recruiting

Human Upper Extremity Allotransplantation

Wounds and Injuries | Amputation, Traumatic | Hand Injuries

United States
University of Arizona
Biotechnology High Performance Computing Software Applications Institute; U...

Recruiting

Caffeine Optimization Versus Standard Caffeine Dosage (2B-2) (2B-2)

Sleep Deprivation | Caffeine

United States
Rahul Aggarwal
National Cancer Institute (NCI); U.S. Army Medical Research Acquisition Activity

Recruiting

64Cu-GRIP B in Patients With Advanced Malignancies

Prostate Cancer | Advanced Solid Tumor | Renal Cancer | Urethral Cancer | Solid Tumor, Adult | Metastatic Castration-resistant Prostate Cancer

United States
U.S. Army Medical Research and Development Command
United States Army Medical Materiel Development Activity

Completed

Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine

Dengue

United States
Robert Flavell, MD, PhD
Bristol-Myers Squibb; U.S. Army Medical Research Acquisition Activity

Recruiting

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Prostate Cancer | Localized Prostate Carcinoma

United States
Rahul Aggarwal
National Institute of Mental Health (NIMH); U.S. Army Medical Research Acquisition...

Recruiting

11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression

Solid Tumor | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Solid Tumor, Adult | Metastatic Castration-resistant Prostate Cancer

United States
MyndTec Inc.
United States Department of Defense; McMaster University; U.S. Army Medical Research... and other collaborators

Completed

Restoration of Reaching and Grasping Function in Individuals With Spinal Cord Injury Using MyndMove® Neuromodulation Therapy

Trauma, Nervous System | Spinal Cord Injuries

United States, Canada
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Institute... and other collaborators

Completed

Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever

Hemorrhagic Fever With Renal Syndrome

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Institute... and other collaborators

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines (HTNV/PUUV)

Hemorrhagic Fever With Renal Syndrome

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

Safety and Immunogenicity of Q Fever Vaccine

Q Fever

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) (NDBR)

Tularemia

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Completed

Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™)

Ricin

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost

Ricin Poisoning

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults (VEE)

Venezuelan Equine Encephalomyelitis Virus Disease

United States
U.S. Army Medical Research and Development Command
US Army Medical Research Institute of Infectious Diseases

Withdrawn

ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With Boost

Ricin Poisoning

United States
U.S. Army Medical Research and Development Command

Recruiting

Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrhagic Fever With Renal Syndrome

Hantaan Virus Nephropathy | Puumala Virus Nephropathy

United States
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Recruiting

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Viral Hemorrhagic Fever

Germany
U.S. Army Medical Research and Development Command

Completed

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) (MMB4(DMS))

Safety and Efficacy

United States
U.S. Army Medical Research and Development Command

Available

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Smallpox | Monkeypox
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54

Malaria,Falciparum

United States
U.S. Army Medical Research and Development Command

Completed

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine (VEE TC-83)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

Eastern Equine Encephalitis

United States
U.S. Army Medical Research and Development Command

Withdrawn

Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

Malaria

United States
U.S. Army Medical Research and Development Command

Withdrawn

Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany (HFRS)

Hemorrhagic Fever With Renal Syndrome

Germany
U.S. Army Medical Research and Development Command

Completed

A Double-Blind, Randomized, Placebo Controlled, Clinical Trial of an Antiplaque Chewing Gum (30 mg) - Phase 2 Proof of Concept in a Generally Healthy Patient Population (APCG)

Plaque Regrowth
U.S. Army Medical Research and Development Command

Withdrawn

Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Study of the Safety of Intravenous Artesunate

Malaria | Malaria, Cerebral

United States
U.S. Army Medical Research and Development Command

Completed

Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)

Leishmaniasis, Cutaneous

Peru
U.S. Army Medical Research and Development Command

Completed

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Completed

Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI) (HOPPS)

Traumatic Brain Injury | Post-concussive Symptoms

United States
U.S. Army Medical Research and Development Command

Recruiting

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Stress Disorders, Post-Traumatic

United States
U.S. Army Medical Research and Development Command

Not yet recruiting

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults (VEE)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine

Dengue Virus

United States

Clinical Trials Sponsored by U.S. Army Medical Research Acquisition Activity

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations